Global Health News and Research

RSS

Hand-held nanotech breathalyzer helps monitor blood glucose in diabetics

A novel hand-held, noninvasive monitoring device that uses multilayer nanotechnology to detect acetone has been shown to correlate with blood-glucose levels in the breath of diabetics. This research is being presented at the 2013 American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition, the world's largest pharmaceutical sciences meeting, in San Antonio, Nov. 10-14.

14 Nov 2013

Novel IRL-1620 compound may be useful in treating Alzheimer's disease

The novel compound IRL-1620 may be useful in treating Alzheimer's disease as it has been shown to prevent cognitive impairment and oxidative stress in animal models. This research is being presented at the 2013 American Association of Pharmaceutical Scientists Annual Meeting and Exposition, the world's largest pharmaceutical sciences meeting, in San Antonio, Nov. 10-14.

14 Nov 2013

Research findings could help decrease risk of dengue

A study by an international team of researchers led by Anna M. Stewart Ibarra, Ph.D., of the Center for Global Health and Translational Science at SUNY Upstate Medical University, has provided public health officials with information that will help decrease the risk of dengue, a life-threatening mosquito-borne viral disease that is now one of the fastest spreading tropical diseases globally.

14 Nov 2013

Researchers create intravaginal ring using MPT to protect women from HIV and unintended pregnancy

A new intravaginal ring (IVR) has been developed for the sustained 90-day co-delivery of tenofovir and levonorgestrel, an anti-human immunodeficiency virus (HIV) drug and a contraceptive.

13 Nov 2013

HIV/AIDS experts awarded over $5M to foster health and medical research skills in India, Africa

Experts in HIV/AIDS at the Johns Hopkins University's School of Medicine and the university's Bloomberg School of Public Health have been awarded more than $5 million by the Fogarty International Center's HIV Research Training Program to foster health and medical research skills in India, Uganda, Ethiopia and Malawi.

13 Nov 2013

Global Coalition Against Child Pneumonia calls for continued investment in innovations, proven tools

Global health advocates today commemorated the fifth annual World Pneumonia Day by calling on global leaders to scale up existing interventions and invest in new diagnostics and treatments to defeat pneumonia. Each year, pneumonia kills more children than AIDS, malaria and tuberculosis combined. Pneumonia took the lives of nearly 1.1 million children under 5 in 2012 alone, with more than 99 percent of these deaths in developing countries, where access to healthcare facilities and treatment is out of reach for many children.

12 Nov 2013

LSTM to celebrate 115 years of dedication in the field of tropical medicine

This Tuesday marks the 115th anniversary of the Liverpool School of Tropical Medicine, the first institution of its kind in the world dedicated to research and teaching in the field of tropical medicine.

11 Nov 2013

Multiple pregnancies: A major public health concern worldwide

Multiple pregnancies are a major public health concern in the United States and the rest of the world due to the significantly higher health risks for both mothers and infants, as well as the impact on healthcare costs.

11 Nov 2013

GHIT Fund makes new investments in potential treatments for malaria, tuberculosis and Chagas disease

The Global Health Innovative Technology Fund, a new public health partnership that is bringing Japanese know-how and investment to the global fight against infectious diseases, announced today grants of US$5.7 million to six global partnerships working on innovative drugs and vaccines against malaria, tuberculosis and Chagas disease.

8 Nov 2013

GHIT Fund grants US$5.7 million to six global partnerships working on vaccines against malaria

The Global Health Innovative Technology Fund (GHIT Fund), a new public health partnership that is bringing Japanese know-how and investment to the global fight against infectious diseases, announced today grants of US$5.7 million to six global partnerships working on innovative drugs and vaccines against malaria, tuberculosis and Chagas disease.

8 Nov 2013

SRI International awarded NIDA contract to study new treatment therapies for substance abuse

SRI International has been awarded a five-year contract valued up to $9.75 million from the National Institute on Drug Abuse to conduct preclinical safety studies of potential new medications to treat substance abuse. SRI researchers will study potential drug-drug interactions between new treatment therapies and common drugs of abuse to assess potential adverse reactions.

6 Nov 2013

Cigna posts strong revenue growth in third quarter 2013

Cigna Corporation today reported strong third quarter 2013 results with each of the Company's business segments posting strong revenue and earnings contributions.

31 Oct 2013

EcoHealth Alliance discovers new SARS-like coronavirus in Chinese horseshoe bats

EcoHealth Alliance, a nonprofit organization that focuses on local conservation and global health issues, announced the discovery of a new SARS-like coronavirus (CoV) in Chinese horseshoe bats.

31 Oct 2013

GHIT Fund to host panel discussion to examine recent successes, setbacks in global health

The Global Health Innovative Technology Fund, along with the New York Academy of Sciences and Japan Society, will host a panel discussion - comprised of preeminent global health experts - to examine recent successes and setbacks in global health and what they see as the secret ingredient to moving a vaccine, cure or diagnostic across the finish line and into the field.

31 Oct 2013

TB Alliance, Svizera Europe partner to create, enable access to new medicines for childhood TB

In an effort to develop and deliver treatments for children with tuberculosis—answering a critical need in public health today—TB Alliance, a not-for-profit organization with the mission to develop better, faster-acting, and affordable drugs for TB, has entered into a collaboration with Svizera Europe, one of the leading global supply and distribution companies for TB treatments.

30 Oct 2013

Researchers complete first phase of landmark study on fungal complications of TB

The first phase of a landmark study of complications of tuberculosis - the first ever carried out in Africa - has been completed by researchers at Wythenshawe Hospital and the University of Manchester working with colleagues in Uganda.

30 Oct 2013

Study compares incidence, impacts of stroke between countries on global scale

Stroke, a condition traditionally associated with old age, is increasingly affecting young and middle aged people, according to a major new analysis from the Global and Regional Burden of Stroke in 1990-2010 study, published in The Lancet.

25 Oct 2013

Study finds persistent deficiency in new therapeutics for neglected diseases

In a study published today in the open-access journal The Lancet Global Health, the Drugs for Neglected Diseases initiative and other researchers report a persistent deficiency in truly new therapeutics for neglected diseases, despite nominal progress and an acceleration in research and development efforts. This continued 'fatal imbalance' in medical R&D points to the urgent need to develop and deliver groundbreaking new treatments for the world's poorest and most neglected patients.

25 Oct 2013

APPG-GTB members express concern on the growing threat of multi-drug resistant TB

In a Lancet Comment discussing the WHO Global Tuberculosis report 2013 published today [Wednesday 23 October], members of the UK All-Party Parliamentary Group on Global Tuberculosis and lead author Professor Ali Zumla from University College London sound an alarm as the growing threat of multi-drug resistant TB to regional and global health security becomes more apparent.

23 Oct 2013

Scientists highlight novel way to develop universal influenza vaccine that can protect against multiple flu strains

A study led by St. Jude Children's Research Hospital scientists highlights a new approach for developing a universal influenza vaccine that could protect against multiple flu strains, including deadly pandemic strains. The research appears today in the advance online edition of the scientific journal Nature Immunology.

22 Oct 2013

Global Health News and Research

Hand-held nanotech breathalyzer helps monitor blood glucose in diabetics

Novel IRL-1620 compound may be useful in treating Alzheimer's disease

Research findings could help decrease risk of dengue

Researchers create intravaginal ring using MPT to protect women from HIV and unintended pregnancy

HIV/AIDS experts awarded over $5M to foster health and medical research skills in India, Africa

Global Coalition Against Child Pneumonia calls for continued investment in innovations, proven tools

LSTM to celebrate 115 years of dedication in the field of tropical medicine

Multiple pregnancies: A major public health concern worldwide

GHIT Fund makes new investments in potential treatments for malaria, tuberculosis and Chagas disease

GHIT Fund grants US$5.7 million to six global partnerships working on vaccines against malaria

SRI International awarded NIDA contract to study new treatment therapies for substance abuse

Cigna posts strong revenue growth in third quarter 2013

EcoHealth Alliance discovers new SARS-like coronavirus in Chinese horseshoe bats

GHIT Fund to host panel discussion to examine recent successes, setbacks in global health

TB Alliance, Svizera Europe partner to create, enable access to new medicines for childhood TB

Researchers complete first phase of landmark study on fungal complications of TB

Study compares incidence, impacts of stroke between countries on global scale

Study finds persistent deficiency in new therapeutics for neglected diseases

APPG-GTB members express concern on the growing threat of multi-drug resistant TB

Scientists highlight novel way to develop universal influenza vaccine that can protect against multiple flu strains

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News